Beatriz Fernandez-Fernandez

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Chronic Kidney Disease

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Clinical kidney journal

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Olga Balafa, Beatriz Fernandez-Fernandez, Alberto Ortiz Arduan, Evangelia Dounousi, Robert Ekart, Charles Joseph Ferro, Patrick B Mark, Jose M Valdivielso, Lucia Del Vecchio, Francesca Mallamaci
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease. Clinical kidney journal 17 (3) (2024)
Olga Balafa, Beatriz Fernandez-Fernandez, Alberto Ortiz Arduan, Evangelia Dounousi, Robert Ekart, Charles Joseph Ferro, Patrick B Mark, Jose M Valdivielso, Lucia Del Vecchio, Francesca Mallamaci
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease. Clinical kidney journal 17 (3) (2024)
Jorge Enrique Rojas-Rivera, Takehiro Hasegawa, Gema Fernandez-Juarez, Manuel Praga, Yuko Saruta, Beatriz Fernandez-Fernandez, Alberto Ortiz Arduan, null null
Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort. Clinical kidney journal 17 (8) (2024)
Olga Balafa, Beatriz Fernandez-Fernandez, Alberto Ortiz Arduan, Evangelia Dounousi, Robert Ekart, Charles Joseph Ferro, Patrick B Mark, Jose M Valdivielso, Lucia Del Vecchio, Francesca Mallamaci
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease. Clinical kidney journal 17 (3) (2024)
Jorge Enrique Rojas-Rivera, Takehiro Hasegawa, Gema Fernandez-Juarez, Manuel Praga, Yuko Saruta, Beatriz Fernandez-Fernandez, Alberto Ortiz Arduan, null null
Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort. Clinical kidney journal 17 (8) (2024)
Sol Carriazo, Alberto Ortiz Arduan, Beatriz Fernandez-Fernandez
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Annals of internal medicine 176 (4) (2023)
Catalina Bosch, Sol Carriazo, Maria José Soler, Alberto Ortiz Arduan, Beatriz Fernandez-Fernandez
Tirzepatide and prevention of chronic kidney disease. Clinical kidney journal 16 (5) (2022)
Catalina Bosch, Sol Carriazo, Maria José Soler, Alberto Ortiz Arduan, Beatriz Fernandez-Fernandez
Tirzepatide and prevention of chronic kidney disease. Clinical kidney journal 16 (5) (2022)